Navigation Links
Second-Generation Female Condom is Now Available in the United States; FC2 Female Condom Will Cost 30 Percent Less than Predecessor
Date:10/1/2009

advocacy organizations in the U.S. have called on donors and implementing agencies to expand women's access to the female condom, which remains the only safe and effective method of woman-initiated HIV prevention currently available.

FC2 will be available in certain retail outlets. As previously announced, FHC is seeking a partner with appropriate experience to promote FC2 directly to consumers in the US.

About The Female Health Company

The Female Health Company (FHC), headquartered in Chicago, IL, is the maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering women dual protection against both sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources Ltd., the holder of exclusive worldwide rights to FC1. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People's Republic of China, South Korea and Japan. FC2 patents have been granted in Australia and South Africa and are pending in various other countries. FHC is the sole manufacturer and marketer of the FC1 and FC2 female condoms in the world. The Female Health Company and its partners currently market the Female Condom under FCFemale Condom®, FC2 Female Condom®, Reality®, Femidom®, Femy®, and Care®.

"Safe Harbor" statement under the Private Securities Litigation Reform Action of 1995:

The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acce
'/>"/>

SOURCE Female Health Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
4. TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
5. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
6. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
7. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
8. New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence
9. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
10. New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence
11. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... -- DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology ... and education markets, announced today that has been no ... disclosed or, to its knowledge, any other reason to ... "We have noticed unusual price and volume increases for ... Steve Barbee , CEO of DigiPath. "While we ...
(Date:7/30/2014)...  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a ... expertise in opioid antagonists, announced today that it ... international research and development foundation. The ... initiatives, including those addressing health issues. Lightlake has ... of naloxone that could widely expand its availability ...
(Date:7/30/2014)... , July 30, 2014   Bluegrass ... focused on innovating lifesaving devices and methods for ... million in Series A financing, which was led ... from the deal will allow Bluegrass Vascular to ... Catheter System, enhance manufacturing capabilities, and proceed with ...
Breaking Medicine Technology:DigiPath No New Corporate Developments 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
... WASHINGTON, Nov. 1 Multiple myeloma is one,of the ... U.S., but,survival rates have risen dramatically over the past ... to new types of drugs,and aggressive therapeutic interventions such ... studies prepublished online in Blood, the,official journal of the ...
... IRVINE, Calif., Nov. 1 IDM Pharma, Inc.,(Nasdaq: ... data,from the Phase 3 mifamurtide (L-MTP-PE) clinical trial (INT-0133). ... funded cooperative,group study conducted by the Children,s Oncology Group ... of patients originally treated in the Phase,3 trial. The ...
Cached Medicine Technology:Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies 2Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies 3Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies 4IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 2IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 3IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 4IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 5IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 6
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... in the specialty and general lighting marketplaces, today ... Retrofit kits. These will allow users to transform ... LED fixtures within minutes. , USHIO America’s Uphoria ... and 6-inch downlight cans, allowing the user to ...
(Date:7/31/2014)... 2014 Thanks to its mildly ... has long been used as a medium for ... monk fruit. However consistent, dependable sourcing of erythritol ... meet food and beverage manufacturers’ increasing needs for ... launched GMO-free ErysweetTM Erythritol. , “Erysweet is ...
(Date:7/30/2014)... Vail and Beaver Creek, Colo., skiers have ... “Blind Skier.” Those skiers and guides are enjoying time ... , a non-profit organization founded in 2001 that matches ... for snow sport opportunities. Visually impaired skiers and snowboarders ... pick up an application to participate in the program ...
(Date:7/30/2014)... (PRWEB) July 31, 2014 CareSource, a ... A. Fecher President and CEO, Wright-Patt Credit Union, to ... is a foremost financial CEO with an extensive background ... of lending and later chief operating officer at Wright-Patt ... has led the Beavercreek-based Wright-Patt Credit Union that has ...
(Date:7/30/2014)... returning National Guard soldiers were more likely to ... life setbacks, including job loss, legal problems, divorce, ... military families. Results of the study by researchers ... are published online in the American Journal ... a major concern for reservists returning home. Nearly ...
Breaking Medicine News(10 mins):Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:Vets' alcohol problems linked to stress on the home front 2
... functions early in myogenesis to help stem cells proliferate in ... Reserve University. The study appears online Jan. 4 in the ... MyoD is a transcription factor that activates muscle-specific genes ... fibers. But MyoD is also expressed at an earlier stage ...
... have pinpointed the prime factors identifying which elderly persons ... The researchers, led by Jeffrey M. Lyness, M.D., ... findings in an article in the December issue of ... treatments for people in the high-risk group hold promise ...
... camps, , THURSDAY, Dec. 31 (HealthDay News) -- Forget ... camps designed for people and their pets are ... one-stop fitness program. , During the 60-minute classes, campers are ... balance and cardiovascular challenges, as well as dog obedience drills. ...
... ANGELES, Dec. 31 Numbers are not just statistics. Sometimes they ... preceding century when lives became daily body counts in televised wars, ... is certainly not the only organization whose staff have worked 24/7 ... staffs of all humanitarian groups and those individual human beings who ...
... Calorie Control ... be leading the way in 2010, according to the Calorie Control Council. Recessionistas will ... ... -- Recessionistas and calorie counters will be leading the way in 2010, according to ...
... , WASHINGTON, Dec. 31 The following ... Tobacco-Free Kids: , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) , ... for health when it becomes the first major tobacco-growing state ... and bars. This new law will protect the right ...
Cached Medicine News:Health News:Study identifies those elderly most at risk for major depression 2Health News:Add Some Woof! to Your Workout 2Health News:Add Some Woof! to Your Workout 3Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 2Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 3Health News:“Recessionistas” and Calorie Counters Lead 2010 Health Trends 2Health News:“Recessionistas” and Calorie Counters Lead 2010 Health Trends 3Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 2Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 3
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi...
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Unique molecular suspension in methanol for ... chromosome, and histology smears. Our special ... rapidly penetrates cellular elements producing unequaled ... detail and unexcelled brilliance in the ...
Wright-Giemsa Stain Solutions...
Medicine Products: